Table 2.
Baseline (n = 16) |
Time point 2 (n = 15) |
Time point 3 (n = 6) |
P | |
---|---|---|---|---|
TNF (pg/mL) | 2.70 (0.99–4.76) | 3.28 (0.99–6.59) | 0.99 (0.99–5.95) | 0.278 |
IL-1β (pg/mL) | 5.39 (1.93–16.89) | 7.11 (1.93–29.13) | 6.48 (1.93–19.21) | 0.012§ |
IFN- γ (pg/mL) | 2.79 (1.6–6.06) | 2.79 (1.6–6.06) | 4.04 (0.47–8.57) | 0.045* |
IL-6 (pg/mL) | 174.48 (104.9–692.51) | 223.74 (142.79–2664.93) | 395.77 (22.93–5594.31) | 0.096 |
IL-8 (pg/mL) | 80.30 (18.72–169.61) | 68.24 (39.84–222.37) | 90.71 (26.43–241.29) | 0.391 |
IL-10 (pg/mL) | 8.78 (3.62–16.49) | 15.73 (5.49–23.98) | 11.1 (1.17–15.23) | 0.009§ |
§Baseline and time point 2 are different. * P is non-significant in post-hoc analysis (P = 1.0).
Baseline refers to the first clinical examination consistent with BD (1.4 ± 1.3 h after study entry); time point 2 refers to the second clinical examination consistent with BD (7 ± 1.2 h after study entry); time point 3 refers to the time of organ retrieval (14.7 ± 2.1 h after study entry).